63 results
P
patients 20 years of age or older who underwent elective surgery for colorectal cancer (CRC)
I/C
triclosan-coated sutures, uncoated sutures
O
incidence of surgical site infections (SSIs)
P
patients with critical limb ischemia (CLI)
I/C
paclitaxel-coated balloons, conventional balloon angioplasty
O
amputation-free survival, target lesion revascularization (TLR)
P
de-novo small-vessel coronary artery disease (SVD) patients
I/C
drug-coated balloons (DCBs), des (DES)
O
late lumen loss (LLL), major adverse cardiovascular events (MACE), all-cause mortality, target lesion revascularization (TLR), target vessel revascularization (TVR), myocardial infarction (MI)
P
patients with in-stent restenosis (ISR)
I/C
drug-coated balloons (DCB), everolimus-eluting stents (EES)
O
minimum lumen diameter, angiographic results, clinical events
P
patients undergoing total gastrectomy for gastric cancer
I/C
J-pouch (JP) reconstruction, standard Roux-en-Y (RY) esophagojejunostomy
O
dumping syndrome, heartburn symptoms
P
599 participants
I/C
drug-coated balloon angioplasty (DCB), percutaneous transluminal angioplasty (PTA)
O
rate of patency
P
patients with de novo coronary artery lesions
I/C
drug-coated balloon (DCB) treatment, non-DCB devices (such as plain old balloon angioplasty (POBA), bare-metal stents (BMS), or drug-eluting stents (DES))
O
target lesion revascularization (TLR)
P
infrapopliteal arterial disease
I/C
vessel preparation techniques, plain old balloon angioplasty (POBA) or drug-coated balloon (DCB) angioplasty
O
12-month primary patency, limb salvage
P
Patients with diabetes mellitus (DM), Patients without diabetes mellitus
I/C
CTO percutaneous coronary intervention (PCI), Non-DM vs. DM patients
O
All-cause mortality, Major adverse cardiovascular events (MACE), Target vessel revascularization (TVR), Myocardial infarction (MI), Japanese chronic total occlusion (J-CTO) score, Prevalence of multivessel (MV) CTO disease
P
Zeng BS, Lin SY, Tu YK, et al
I/C
Prevention of Postdental Procedure Bacteremia
O
J Dent Res 2019 Oct;98(11):1204-1210
